Skip to main content
. Author manuscript; available in PMC: 2023 Feb 10.
Published in final edited form as: Clin Infect Dis. 2022 Jul 5;76(3):e920–e929. doi: 10.1093/cid/ciac556

Figure 4.

Figure 4

Selected summary forest plots showing sensitivity and specificity estimates (with 95% CI) for MTBDRplus and MTBDRsl. Importantly, only patients first detected as TB positive (top two rows) can generate an actionable LPA DST result. Estimates for smear-negatives were lower than smear-positives and, overall, estimates for SLIDs were lower than for FQs. All estimates improved in favour of LPAs after discrepant resolution.

Abbreviations: TB-tuberculosis, FQ-fluoroquinolones, SLID-second line injectable drugs